Werewolf Therapeutics

HOWLNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$19.299 M

$0.40 -1.42%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$60.8M

Loss-making

Shares outstanding

48,599,066

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#397Atossa TherapeuticsATOS$20.3M
#398CelularityCELU$20.3M
#399Werewolf TherapeuticsHOWL$19.3M
#400GridAI TechnologiesGRDX$18.9M
#401Rocket OneRKTO$18.9M

Where these numbers come from

Share counts and financials for Werewolf Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.